Skip to content

Clinical trials

Phase 3 Genetic Diseases, Inborn trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 3 Country / region: United Kingdom Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20131
20142
20163
20173
20185
20191
20213
20222
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting7
Terminated3
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
Vertex Pharmaceuticals Incorporated4
GenSight Biologics3
Genzyme, a Sanofi Company2
Kastle Therapeutics, LLC2
PTC Therapeutics2
Quince Therapeutics S.p.A.2
Avidity Biosciences, Inc.1
Cangene Corporation1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn30
Nervous System Diseases10
Genetic Diseases, X-Linked8
Musculoskeletal Diseases8
Hematologic Diseases7
Infant, Newborn, Diseases5
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited4
Bone Diseases4
Coagulation Protein Disorders4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.